Notably, serum ATIC levels in patients with MM exhibited a decreasing trend as the treatment response improved, and the Remission Group showed a marked decrease compared to the Active Disease Group (p < 0.05).
← all phrases
“a decreasing trend”
Sighted at
p=0.09
In the literature
The control and DSEO -3 groups showed a decreasing trend, with peaks on days 1, 6, and 9 for the control and day 9 for the DSEO -3 group ( P < 0.05).
Following YGS treatment, fecal status, mental status, and dehydration scores showed a decreasing trend on Day 7, ultimately showing no significant difference compared to the Ctrl group ( p > 0.05).
(2) In the frequency domain, both LF and LF/HF significantly increased after sleep deprivation ( p < 0.05), whereas HF showed a decreasing trend that did not reach statistical significance ( p > 0.05).
Bax and c-Caspase3 expression were increased, while Bcl2 expression showed a decreasing trend ( p < 0.05) ( Figure 4 I).
(3) Compared with preoperative levels, both groups showed a decreasing trend in SOD and NSE and an increasing trend in NGF and BDNF after surgery, with the observation group showing more significant and sustained changes over time (P < 0.05).
By contrast, there was a decreasing trend in the consumption of aminoglycosides, cephalosporins and inhibitors ( P < 0.05).
Compared to the Con group, the ingested nitrogen of the piglets in the Rha group, Lac group, and mix group was significantly increased ( P < 0.05), fecal nitrogen, urinary nitrogen, and total nitrogen emissions showed a decreasing trend, the apparent nitrogen digestibility of Rha and Lac groups tended to increase; the apparent nitrogen digestibility of the mix group increased by 1.88% ( P < 0.05), and the nitrogen deposition rate increased respectively increased by 4.17, 4.49, and 5.65% ( P < 0.05), and the nitrogen utilization rate increased by 2.82, 3.23, and 3.70%, respectively ( P < 0.05). 3.2.
The interpretation of trends followed predefined statistical criteria: a decreasing trend (p-value<0.05 with a negative coefficient), an increasing trend (p-value<0.05 with a positive coefficient), and a stable trend (p-value≥0.05), according to a validated methodology ( 19 ).
Although the contents of glucose and fructose showed a decreasing trend, the differences were not statistically significant ( p > 0.05).
Effects of Morusin and MAS on the Water Content in the Rat Skin The skin water content of the paw pads in the model group was reduced compared to the normal group ((Paw pad of left forelimb: model group, 29.2 ± 1.7 versus control group, 32.7 ± 2.5, P<0.05; paw pad of right forelimb: model group, 28.7 ± 2.5 versus control group, 32.8 ± 2.3, P<0.05; paw pad of left hindlimb: model group, 30.4 ± 1.3 versus control group, 32.4 ± 1.2, P<0.05; paw pad of right hindlimb: model group, 29.7 ± 1.1 versus control group, 32.8 ± 2.2, P<0.05; n = 10; Figure 2 ), with a decreasing trend in back skin water content that was not statistically significant (Back: model group, 24.0 ± 0.6 versus control group, 24.8 ± 1.1, P>0.05; n = 10; Figure 2 ).
Compared with the stress treatments, the mitigation treatments (50Pb + , 150Pb + , 50Zn + , and 100Zn + ) showed a decreasing trend in MDA content, with significant differences ( p < 0.05), which were reduced by 12.99%, 15.00%, 12.66%, and 9.71%, respectively.
Following heparin administration, serum HP levels increased significantly ( p < 0.05), while MK and PTN levels showed a decreasing trend that did not reach statistical significance ( p > 0.05).
The effect of Agari-5 on cardiac function in rats with MI: As shown in Figure 1B and C , rat cardiac ultrasound images revealed a decreasing trend in left ventricular ejection fraction and left ventricular short-axis shortening fraction levels in the model group compared with the control group ( P > 0.05), and an increasing trend in the Agari-5 group compared with the model group ( P > 0.05).
After the intervention of adding taurine, the content of iNOS, and NO were significantly decreased ( p < 0.05), but the IL-1 β content showed a decreasing trend but no statistical difference (p > 0.05).
The Ace index was significantly lower in the PA_HFD group than in the HFD group ( p < 0.01), and the Chao index showed a decreasing trend ( p > 0.05) ( Figure 6 A,B).
After 6 weeks of intervention, EG showed a decreasing trend in both WA% and Pi10 across all GOLD grades, with the most notable improvement observed in GOLD II–III patients ( P < 0.05), suggesting initial amelioration of airway remodeling.
Gestational age at delivery differed significantly across PPBMI groups ( p < 0.05), with a decreasing trend observed in higher PPBMI categories; Neonatal birthweight differed significantly across PPBMI groups ( p < 0.05), showing a positive trend with higher PPBMI.
The Sost expression in alendronate group showed a decreasing trend, which were significantly lower than that in Dkk1-mAb group ( P < 0.05) ( Fig. 2 F). 3.4.
In contrast to the OTR, the WVTR values exhibit a decreasing trend ( p < 0.05) as the concentration of ZnO-NPs increases.
The value of I.S in the Sham + V group showed a decreasing trend compared with the baseline group ( P > 0.05).
Also, the EB value shows a decreasing trend until the geranium EO nanoemulsion reaches 1% (67.96% ± 4.70%) ( p < 0.05).
Among saturated fatty acids, short- and medium-chain fatty acids (C10:0, C12:0, and C14:0) showed a decreasing trend with increasing replacement level ( p < 0.05), while palmitic acid (C16:0) remained relatively stable ( p > 0.05).
Conversely, levels of HDL-C, albumin, and eGFR showed a decreasing trend with increasing TyG quartile ( P < .05).
Although a decreasing trend was observed, the level of p-AMPKα−1/AMPKα−1 did not reveal a statistically remarkable difference between the two groups ( P > 0.05).